Orgenesis Reports Material Agreement, New Debt, Unregistered Equity Sales
Ticker: ORGS · Form: 8-K · Filed: Jan 5, 2024 · CIK: 1460602
| Field | Detail |
|---|---|
| Company | Orgenesis INC. (ORGS) |
| Form Type | 8-K |
| Filed Date | Jan 5, 2024 |
| Risk Level | medium |
| Pages | 4 |
| Reading Time | 5 min |
| Key Dollar Amounts | $771,484, $0.0001, $0.85, $485,000, $175,000 |
| Sentiment | mixed |
Complexity: simple
Sentiment: mixed
Topics: debt, equity-offering, material-agreement, capital-raise
TL;DR
**Orgenesis just took on new debt and sold unregistered shares, watch for dilution.**
AI Summary
Orgenesis Inc. filed an 8-K on January 5, 2024, reporting events from January 1, 2024, related to entering a material definitive agreement, creating a direct financial obligation, and unregistered sales of equity securities. This indicates the company is likely raising capital or restructuring debt, which could dilute existing shareholders if new shares were issued, or impact future earnings if new debt was incurred. Investors should investigate the specifics of these agreements to understand the potential impact on their holdings.
Why It Matters
These events signal significant financial activities, potentially impacting Orgenesis Inc.'s capital structure, future profitability, and the value of existing shares through dilution or increased debt burden.
Risk Assessment
Risk Level: medium — The filing indicates new financial obligations and unregistered equity sales, which could lead to dilution or increased financial risk for Orgenesis Inc. shareholders.
Analyst Insight
A smart investor would seek out the full details of the 'Material Definitive Agreement' and the 'Unregistered Sales of Equity Securities' to assess potential dilution and the nature of the new financial obligations before making any investment decisions regarding Orgenesis Inc.
Key Players & Entities
- Orgenesis Inc. (company) — the registrant filing the 8-K
- January 1, 2024 (date) — date of the earliest event reported
- January 5, 2024 (date) — date the 8-K was filed
- Nevada (company) — state of incorporation for Orgenesis Inc.
Forward-Looking Statements
- Orgenesis Inc. will provide more details on the material definitive agreement and financial obligation in subsequent filings or press releases. (Orgenesis Inc.) — high confidence, target: Q1 2024
- The unregistered sales of equity securities will lead to an increase in the total outstanding shares of Orgenesis Inc. (Orgenesis Inc.) — high confidence, target: Q1 2024
FAQ
What specific items were reported in this 8-K filing by Orgenesis Inc.?
Orgenesis Inc. reported 'Entry into a Material Definitive Agreement,' 'Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant,' and 'Unregistered Sales of Equity Securities' as events occurring on January 1, 2024.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on January 1, 2024.
What is the filing date of this 8-K for Orgenesis Inc.?
The 8-K for Orgenesis Inc. was filed on January 5, 2024.
What is Orgenesis Inc.'s state of incorporation?
Orgenesis Inc.'s state of incorporation is Nevada.
What is the business address of Orgenesis Inc. as stated in the filing?
The business address of Orgenesis Inc. is 20271 Goldenrod Lane, Germantown, MD 20876.
Filing Stats: 1,256 words · 5 min read · ~4 pages · Grade level 11.9 · Accepted 2024-01-05 06:02:39
Key Financial Figures
- $771,484 — f the convertible loans outstanding was $771,484 with interest rates of 8% per annum (ba
- $0.0001 — f the Company's common stock, par value $0.0001 per share (the "Common Stock"), at $0.8
- $0.85 — 0001 per share (the "Common Stock"), at $0.85 per share, at Nir's discretion, and (ii
- $485,000 — ible loan dated March 27, 2023 of which $485,000 principal amount plus interest is outst
- $175,000 — tible loan dated July 26, 2023 of which $175,000 principal amount plus interest is outst
- $75,000 — e loan dated November 17, 2023 of which $75,000 principal amount plus interest is outst
- $331,099 — ipal amount of the loans outstanding is $331,099 with interest rates ranging from 0% to
- $50,000 — 0% loan dated October 1, 2023 of which $50,000 principal amount plus interest is outst
Filing Documents
- form8-k.htm (8-K) — 49KB
- ex4-1.htm (EX-4.1) — 84KB
- ex4-2.htm (EX-4.2) — 80KB
- ex10-1.htm (EX-10.1) — 26KB
- ex10-2.htm (EX-10.2) — 28KB
- 0001493152-24-001142.txt ( ) — 479KB
- orgs-20240101.xsd (EX-101.SCH) — 3KB
- orgs-20240101_lab.xml (EX-101.LAB) — 34KB
- orgs-20240101_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ORGENESIS INC. Date: January 5, 2024 By: /s/ Vered Caplan Vered Caplan Chief Executive Officer